Finance

Lists
603439:SHA
Guizhou Sanli Pharmaceutical Co Ltd
CNÂ¥12.17
-4.62%
(-0.59) 1D
Sep 8, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603439...
Open
CNÂ¥12.84
High
CNÂ¥12.84
Low
CNÂ¥12.17
Mkt. cap
4.94B
Avg. vol.
13.60M
Volume
10.48M
Dividend
0.49%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 30, 2026
P/E ratio
1,138.45
52-wk high
CNÂ¥17.46
52-wk low
CNÂ¥9.51
EPS
CNÂ¥0.01
No. of employees
2K
Open
CNÂ¥12.84
High
CNÂ¥12.84
Low
CNÂ¥12.17
Mkt. cap
4.94B
Avg. vol.
13.60M
Volume
10.48M
Dividend
0.49%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 30, 2026
P/E ratio
1,138.45
52-wk high
CNÂ¥17.46
52-wk low
CNÂ¥9.51
EPS
CNÂ¥0.01
No. of employees
2K
About Guizhou Sanli Pharmaceutical Co Ltd
CEO-
Employees1.89K
FoundedSep 22, 1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
336.67M
664.34M
381.73M
177.59M
Cost of goods sold
95.83M
193.81M
107.78M
53.09M
Cost of revenue
95.83M
193.81M
107.78M
53.09M
Research and development expenses
2.53M
8.52M
2.37M
4.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
238.41M
348.40M
207.24M
134.75M
Operating expense
232.66M
380.37M
218.01M
128.41M
Total operating expenses
328.49M
574.19M
325.78M
181.50M
Operating income
8.18M
90.16M
55.95M
-3.91M
Other non operating income
875.14K
981.00
-536.33K
-6.00M
EBT including unusual items
-1.26M
-24.89M
51.43M
-7.70M
EBT excluding unusual items
7.38M
88.32M
51.42M
-5.28M
Income tax expense
457.80K
10.64M
6.29M
-349.94K
Effective tax rate
-36.44%
-42.73%
12.23%
4.55%
Other operating expenses
-3.08M
20.15M
3.11M
-5.36M
Net income
-2.27M
-34.53M
44.41M
-7.23M
Net profit margin
-0.68%
-5.20%
11.63%
-4.07%
Earnings per share
-
-
-
-
Interest and investment income
-
2.08M
687.92K
4.68M
Interest expense
-1.68M
-3.91M
-4.68M
-36.63K
Net interest expenses
-1.68M
-1.84M
-3.99M
4.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.67M
108.35M
74.14M
12.72M
Gain or loss from assets sale
92.04K
115.56K
-
-309.85K
AI content may include mistakes. Learn more
Google apps